Results

Total Results: 1,877 records

Showing results for "evaluated".

261. Meditation Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
     January 01, 2014 - If the trial did not evaluate credibility, or if it evaluated credibility but did not find it comparable … These conclusions did not change when we evaluated TM separately from other mantra meditation programs … the effect of meditation on substance use,33,34,54,67 2 evaluated eating,43,50 and 7 evaluated sleep … Two mindfulness trials evaluated weight as an outcome, and it was a primary outcome for both. … Three TM trials evaluated weight as a secondary outcome.

262. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
     July 06, 2015 - Since ONTARGET directly compared the same drugs as were evaluated in the placebo-controlled HOPE and … ACE inhibitors or ARBs did not significantly impact any of the endpoints evaluated. … Since ONTARGET directly compared the same drugs as were evaluated in the placebo- controlled HOPE and … ACE inhibitors or ARBs did not significantly impact any of the endpoints evaluated. … When we evaluated the impact of baseline risk on efficacy, there was a suggestion that ARBs might

263. ADHD-Update-protocol-160818 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-update_research-protocol.pdf
     August 18, 2016 - The use of EEG-based systems to support the diagnosis of ADHD will also be evaluated. … Acceptability of treatment will also be evaluated as an intermediate outcome. … EEG-based systems will also be evaluated. … The use of EEG-based systems to support the diagnosis of ADHD will also be evaluated. … The use of EEG-based systems, imaging, or executive function approaches will be evaluated in the

264. Kidney-Disease-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
     January 01, 2012 - When no RCTs were identified that evaluated a CKD screening or monitoring intervention and reported … observational studies were not identified through a comprehensive literature search, whenever possible we evaluated … .19 For each treatment comparison and major outcome, overall strength of evidence for the RCTs was evaluated … Research and Quality and the Effective Health Care Program.20 Briefly, strength of the evidence was evaluated … Note: For all-cause mortality and end-stage renal disease, the strength of the evidence was evaluated

265. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
     June 16, 2010 - of the evidence and expert opinion supporting recommendations to update specific key questions were evaluated … For this reason, both forms of epoetin will be evaluated in this review. … LASA, VAS, and CLAS scales will be excluded Tumor response will only be evaluated in studies that … New studies will be evaluated against inclusion/exclusion criteria in the same manner as all other studies … Between-study heterogeneity will be evaluated by examining measures of between-study variability (e.g

266. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
     May 01, 2010 - The two reviewers also independently evaluated the applicability to real-world practice of the total … The RCTs evaluated patients who were not on oral anticoagulation therapy (OAT) and had intracerebral … • rFVIIa use vs. usual care had no effect on hematoma growth but, in the one study that evaluated it … One of the RCTs assessed prophylactic rFVIIa use, whereas the rest of the studies evaluated treatment … benefits and harms of rFVIIa, our findings include: • Mortality and thromboembolic events could not be evaluated

267. 8 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
     November 01, 2008 - Identifying Harms To Be Evaluated 2 CERs should always assess harms that are important to decisionmakers … unpublished myocardial infarction data from older trials found an increased risk with high doses of all evaluated … common with cohort studies, it is difficult to establish causality because exposures, and outcomes are evaluated … exposures and outcomes, and blinded assessment of outcomes. 30,52-54 Several studies have empirically evaluated … favorable outcomes than did studies with other funding sources. 57,59 Because all of these studies evaluated

268. 8 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
     November 01, 2008 - Identifying Harms To Be Evaluated 2 CERs should always assess harms that are important to decisionmakers … unpublished myocardial infarction data from older trials found an increased risk with high doses of all evaluated … common with cohort studies, it is difficult to establish causality because exposures, and outcomes are evaluated … exposures and outcomes, and blinded assessment of outcomes. 30,52-54 Several studies have empirically evaluated … favorable outcomes than did studies with other funding sources. 57,59 Because all of these studies evaluated

269. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
     January 01, 2006 - • No studies evaluated the comparative efficacy of salsalate or aspirin vs. a nonaspirin NSAID. … • In fair-quality meta-analyses of arthritis trials, most of which evaluated short-term use, celecoxib … and results may not be directly applicable to the United States because the positive trials primarily evaluated … medications with topical preparations • Topical NSAIDs: efficacy • Studies of topical NSAIDs typically evaluated … Balance of evidence and harms Each of the analgesics evaluated in this report was associated with a

270. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
     March 24, 2017 - Given comments during peer review we re- evaluated the body of evidence and we have changed the strength … Based on comments during peer review, we re-evaluated the body of evidence, and given the small studies … We re-evaluated the body of evidence, given the comments of the reviewers, and have revised the strength … However, we re-evaluated this body of evidence and based on, the small studies (and therefore some

271. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
     March 24, 2017 - Given comments during peer review we re- evaluated the body of evidence and we have changed the strength … Based on comments during peer review, we re-evaluated the body of evidence, and given the small studies … We re-evaluated the body of evidence, given the comments of the reviewers, and have revised the strength … However, we re-evaluated this body of evidence and based on, the small studies (and therefore some

272. Alcohol-Misuse-Drug-Therapy Clinician (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
     February 01, 2016 - .†† Most studies evaluated medications in combination with a psychosocial cointervention; the potential … The studies typically evaluated the use of medications along with psychosocial cointerventions. ��

273. Assessing the Quality of Individual Studies (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/assessing-quality.ppt
     January 01, 2010 - predefined criteria listed here have been demonstrated to influence study outcomes and should be routinely evaluated … for Observational Studies (I) Nonrandomized studies have additional sources of bias that need to be evaluated

274. Breast-Cancer-Medications Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
     July 01, 2012 - review (or guidelines) whose results identified another treatment as significantly superior to the one evaluated … Tamoxifen reduces breast cancer outcomes in subgroups evaluated in prevention trials based on age … Raloxifene reduces breast cancer outcomes in subgroups evaluated in prevention trials based on … New Evidence: Tamoxifen reduces breast cancer outcomes in subgroups evaluated in … Raloxifene reduces breast cancer outcomes in subgroups evaluated in prevention trials based on age,

275. Searching for Relevant Studies (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/searching.ppt
     January 01, 2011 - In the first study, the sensitivity and specificity of using MEDLINE versus nine databases was evaluated … English Only or All Languages (I) This study evaluated 42 systematic reviews comprising 662 RCTs. … However, when complementary and alternative medicine was evaluated, the protective effect estimate was … 63% smaller than when language-inclusive reviews were evaluated. … Grey Literature In one study, five systematic reviews were evaluated to determine the impact of grey

276. Acute Treatments for Episodic Migraine: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
     August 01, 2022 - Lidocaine No study in the original report evaluated this comparison. … Placebo No study in the original report evaluated this specific NSAID. … Placebo No study in the original report evaluated this comparison. … Placebo No study in the original report evaluated this comparison. … Placebo No study in the original report evaluated this comparison.

277. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-genetic.ppt
     June 01, 2012 - analyte was investigated (e.g., specification of which alleles, genes, or biochemical analytes were evaluated … Depending on the enzyme and polymorphism being evaluated, the variation in enzyme activity over time … Assessment of newly identified polymorphisms (such as on chromosome 9p21) should be evaluated in context … Genetic association studies should generally report whether the frequencies of the alleles being evaluated … When clinical factors associated with risk are well known, genetic tests should be evaluated for added

278. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-genetic.ppt
     June 01, 2012 - analyte was investigated (e.g., specification of which alleles, genes, or biochemical analytes were evaluated … Depending on the enzyme and polymorphism being evaluated, the variation in enzyme activity over time … Assessment of newly identified polymorphisms (such as on chromosome 9p21) should be evaluated in context … Genetic association studies should generally report whether the frequencies of the alleles being evaluated … When clinical factors associated with risk are well known, genetic tests should be evaluated for added

279. Choice-Of-Mean White-Paper (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/choice-of-mean_white-paper.pdf
     April 01, 2015 - We also evaluated whether the impact qualitatively varied by the comparator and alternative random … Therefore, in this meta-epidemiological study, we empirically evaluated how the choice of using change … In addition, we evaluated how different random effect models might affect the impact of the choice of … Only meta-analyses of RCTs were included in this study, and we specifically evaluated MD only. … We avoided including more than one CER that evaluated the same continuous outcome (duplicate outcome

280. Management of Infantile Hemangioma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_policymaker.pdf
     June 01, 2016 - * These considerations were not evaluated in the systematic review but are offered to assist policymakers